Compass Therapeutics | 10-Q:季度報表
Compass Therapeutics | 8-K:Compass Therapeutics公佈2024年第一季度財務業績並提供公司最新情況
Compass Therapeutics | ARS:年度報告
Compass Therapeutics | DEFA14A:其他
Compass Therapeutics | DEF 14A:股東委託書決議
Compass Therapeutics | 8-K:重大事件
Compass Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-OrbiMed Advisors LLC(13.7%),OrbiMed Capital GP V LLC(11.1%)等
Compass Therapeutics | 10-K:年度報表
Compass Therapeutics | 8-K:重大事件
Compass Therapeutics | 4:持股變動聲明-董事 Boylan James P
Compass Therapeutics | 4:持股變動聲明-董事 GORDON CARL L
Compass Therapeutics | 4:持股變動聲明-董事 GRAY MARY ANN
Compass Therapeutics | 4:持股變動聲明-董事 LINDAHL RICHARD S
Compass Therapeutics | 4:持股變動聲明-董事 Ferneau Philip
Compass Therapeutics | 4:持股變動聲明-董事 Chiniara Ellen
Compass Therapeutics | 4:持股變動聲明-高管 Bisker-Leib Vered
Compass Therapeutics | 4:持股變動聲明-高管 Schuetz Thomas J.
Compass Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-FMR LLC(3.570%),Abigail P. Johnson(3.570%)
Compass Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Adage Capital Partners, L.P.(7.75%),Adage Capital Partners GP, L.L.C.(7.75%)等
Compass Therapeutics | SC 13G:超過5%持股股東披露文件-Janus Henderson Group plc(6.0%),Janus Henderson Biotech Innovation Master Fund Ltd(5.4%)
暫無數據